Related Experiment Video

Updated: Jun 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Changing trends in hepatitis C infection over the past 50 years in Japan

Hobyung Chung1, Taisuke Ueda, Masatoshi Kudo

  • 1Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan.

Intervirology
|January 14, 2010
PubMed

Insights

Hepatitis C virus (HCV) infection, a primary cause of liver cancer (hepatocellular carcinoma or HCC) in Japan, is declining in older populations. While new HCV transmissions occur, overall HCC incidence is decreasing due to reduced HCV prevalence.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatocellular carcinoma (HCC) is a significant cause of cancer death in Japan, with Hepatitis C virus (HCV) being the primary etiological agent.
  • HCV genotype 1b, prevalent in Japan, spread historically through specific demographics and medical practices.
  • HCV infection rates are notably higher in older individuals (>55 years) compared to younger generations.

Purpose of the Study:

  • To analyze the epidemiological trends of Hepatitis C virus infection and its association with hepatocellular carcinoma in Japan.
  • To investigate the changing patterns of HCV genotypes and transmission routes, particularly among different age groups and risk populations.
  • To assess the impact of declining HCV prevalence on the incidence of HCC in Japan.

Main Methods:

  • Epidemiological analysis of HCV infection prevalence across different age demographics in Japan.
  • Review of historical HCV transmission factors, including injecting drug use and medical procedures.
  • Examination of trends in HCC incidence and mortality in relation to HCV prevalence and genotype distribution.

Main Results:

  • Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality in Japan, predominantly linked to Hepatitis C virus (HCV).
  • The prevalence of HCV infection is significantly lower in younger populations compared to those over 55, indicating a generational decline.
  • Despite ongoing sporadic transmissions, particularly among young injecting drug users (IDUs), the overall incidence of HCC is decreasing, largely attributed to the reduced prevalence of HCV-related cases.

Conclusions:

  • The declining prevalence of Hepatitis C virus infection, especially among older generations, is leading to a decrease in hepatocellular carcinoma incidence in Japan.
  • While Hepatitis C virus genotype 2 shows some spread among injecting drug users, these patients may respond better to antiviral therapies.
  • Public health strategies focusing on reducing HCV transmission and increasing treatment efficacy are crucial for further mitigating the burden of liver cancer.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...